Mutares Prepares for a Pivotal Week as Audited Accounts Set to Reveal Balance Sheet Health
27.04.2026 - 21:21:44 | boerse-global.de
The Munich-based holding company is navigating a period of unusual contrasts. On one hand, Mutares is assembling what it describes as the largest exit pipeline in its corporate history. On the other, its shares remain roughly 17% lower since the start of the year, trading at €24.85 — barely above the 52-week low of €23.60. The tension between these two realities is expected to come into sharper focus tomorrow when the company releases its audited 2025 annual report.
A Trio of Exits in the Pipeline
Mutares has initiated several disposal processes at varying stages of maturity. Peugeot Motocycles is slated for a management buyout, while the Polish bus operator Relobus is being lined up for sale to infrastructure investor Infracapital. Both transactions are scheduled to close in the second quarter of 2026. Additionally, a separate ongoing sales process could generate proceeds in the triple-digit millions, assuming it completes as anticipated.
The portfolio company Magirus is attracting particular attention. Its order book now stands at well over €800 million, securing full capacity utilisation for 2026 and a significant portion of 2027. The defence business is expanding, and Mutares is actively evaluating two exit routes: an initial public offering or a direct sale. A decision is expected shortly.
Fresh Acquisitions and a US Push
On the buy side, portfolio company Amaneos is acquiring a European automotive lighting business with annual sales of approximately $235 million. The HiLo Group is taking over a car-top systems operation generating around $85 million in revenue. Both deals remain subject to regulatory approval.
Should investors sell immediately? Or is it worth buying Mutares?
The capital increase completed in April raised roughly €105 million through the placement of approximately 4.27 million new shares at €24.50 each. Around 80% of the proceeds are earmarked for US expansion, with the remaining 20% earmarked for balance sheet strengthening. Mutares has identified a pipeline of roughly 15 potential acquisition targets in the US, primarily in energy, chemicals, infrastructure and automotive, with an estimated combined revenue of approximately €4.8 billion. The appeal of the American market lies in higher exit multiples compared with Europe.
The Balance Sheet Challenge
Beneath the operational activity lies a structural concern. The ratio of net debt to equity breached the threshold stipulated in the company's bond covenants, triggered by valuation effects, subdued transaction activity in the fourth quarter of 2025 and higher lease liabilities. Bondholders have granted a waiver, providing temporary relief but not a permanent solution.
Starting in the second quarter, Mutares will repurchase at least €25 million per quarter of its 2023/2027 bond. The true state of the financial metrics will become clear tomorrow with the publication of the 2025 annual report, which will also include a dividend proposal.
Mutares at a turning point? This analysis reveals what investors need to know now.
Outlook and Key Dates
Management has reaffirmed its 2026 guidance, targeting consolidated group revenue between €7.9 billion and €9.1 billion, with a holding-level net profit of €165 million to €200 million. The first-quarter trading update is scheduled for 12 May, followed by the annual general meeting on 3 July.
For investors, tomorrow's audited accounts represent the first comprehensive data point since the capital increase and the covenant waiver. Whether the combination of a potential Magirus exit, the US pipeline and a dividend announcement can reverse the share price trajectory will depend heavily on the numbers that emerge.
Ad
Mutares Stock: New Analysis - 27 April
Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Mutares Aktien ein!
Für. Immer. Kostenlos.
